Robert J Cherney

Years Active: 2020-2021
Publications (10 Years): 3

Bristol-Myers Squibb Company

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Bristol-Myers Squibb Company

United States

Research Fellow :: Research and Development

Publications

Michael G Yang, Zili Xiao, Rulin Zhao, Andrew J Tebben, Bei Wang, Robert J Cherney, Douglas G Batt, Gregory D Brown, Mary Ellen Cvijic, John V Duncia, Michael A Gallela, Daniel S Gardner, Purnima Khandelwal, Mary F Malley, Jian Pang, Anne V Rose, Joseph B Santella, Amy A Sarjeant, Songmei Xu, Arvind Mathur, Sandhya Mandlekar, Ragini Vuppugalla, Qihong Zhao, Percy H Carter
Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2. ACS medicinal chemistry letters 12 (6) (2021)
Robert J Cherney, Prakash Anjanappa, Kumaravel Selvakumar, Douglas G Batt, Gregory D Brown, Anne V Rose, Ragini Vuppugalla, Jing Chen, Jian Pang, Songmei Xu, Melissa Yarde, Andrew J Tebben, Venkatram Reddy Paidi, Mary Ellen Cvijic, Arvind Mathur, Joel C Barrish, Sandhya Mandlekar, Qihong Zhao, Percy H Carter
BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate. ACS medicinal chemistry letters 12 (11) (2021)
Lyndon A M Cornelius, Jianqing Li, Daniel Smith, Subramaniam Krishnananthan, Shiuhang Yip, Dauh-Rurng Wu, Joseph Pawluczyk, Darpandeep Aulakh, Amy A Sarjeant, James Kempson, Joseph A Tino, Arvind Mathur, T G Murali Dhar, Robert J Cherney
Synthesis of 1-(tert-Butyl) 4-Methyl (1R,2S,4R)-2-Methylcyclohexane-1,4-dicarboxylate from Hagemann's tert-Butyl Ester for an Improved Synthesis of BMS-986251. The Journal of organic chemistry 85 (16) (2020)

Robert J Cherney.css-eqlu8i{font-size:small;padding-left:4px;}